Fresenius Kabi hat dies direkt geteilt
With breast cancer being the most common cancer among women globally – and responsible for around a quarter of all cancers in women with millions of new cases every year – October is an important awareness month. And one that is very close to us at Fresenius Kabi as we strive to make a difference in high-quality oncological care. Our respective portfolio plays an important role in chemotherapy protocols, and through our ambitions in the biopharmaceuticals segment, we are improving access to quality cancer care. Especially inspiring to me is the personal dedication I experienced this month throughout the Kabi organization: from charity runs to awareness events, our colleagues across the world stand united, embodying the values we hold dear. Today, I'm particularly moved by the story of my colleague Shanu, a breast cancer survivor who courageously shares her journey and how it has given her a renewed sense of purpose. Her story is a powerful reminder of resilience and an inspiring example of why we do what we do at Fresenius Kabi. #BreastCancerAwareness #FreseniusKabi #TeamFresenius #CommittedToLife